| | | | Aurobindo Pharma receives final approvals for Montelukast Sodium Tablets and Chewable Tablets | 08/06/12 09:43 | | | | Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated August 06, 2012, titled "Aurobindo Pharma receives final approvals for Montelukast Sodium Tablets and Chewable Tablets".
Press Release:
"Aurobindo Pharma Limited is pleased to announce that the Company has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Montelukast Sodium Tablets 10mg (ANDA 202468) and Montelukast Sodium Chewable Tablets 4mg and 5mg (ANDA 202096). The products are ready for a first-day launch." (For more details kindly refer Corporate Announcements on www.bseindia.com). | |
|